Anjali Katyal Nath, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cyanides | 5 | 2023 | 83 | 1.980 |
Why?
|
| Antidotes | 3 | 2023 | 138 | 1.190 |
Why?
|
| Zebrafish | 7 | 2023 | 2996 | 1.020 |
Why?
|
| Poisoning | 1 | 2023 | 249 | 0.790 |
Why?
|
| Carnitine | 1 | 2019 | 246 | 0.650 |
Why?
|
| Sarcopenia | 1 | 2023 | 368 | 0.620 |
Why?
|
| Glyoxylates | 2 | 2023 | 10 | 0.440 |
Why?
|
| Glucose | 3 | 2019 | 4398 | 0.440 |
Why?
|
| Riboflavin | 1 | 2013 | 108 | 0.430 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 1222 | 0.420 |
Why?
|
| Cisplatin | 1 | 2017 | 1662 | 0.380 |
Why?
|
| Cardiovascular System | 2 | 2009 | 831 | 0.350 |
Why?
|
| Endocardial Cushions | 1 | 2008 | 13 | 0.330 |
Why?
|
| Homeostasis | 1 | 2019 | 3339 | 0.320 |
Why?
|
| Nitric Oxide | 3 | 2009 | 2132 | 0.320 |
Why?
|
| Leptin | 5 | 2008 | 1600 | 0.270 |
Why?
|
| Insulin Resistance | 1 | 2019 | 3864 | 0.270 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2019 | 2504 | 0.270 |
Why?
|
| Neovascularization, Physiologic | 5 | 2004 | 1351 | 0.260 |
Why?
|
| Mesoderm | 1 | 2008 | 686 | 0.250 |
Why?
|
| Yolk Sac | 1 | 2004 | 75 | 0.240 |
Why?
|
| Epithelium | 1 | 2008 | 1679 | 0.220 |
Why?
|
| Myography | 1 | 2023 | 109 | 0.210 |
Why?
|
| Rabbits | 3 | 2022 | 4894 | 0.200 |
Why?
|
| Receptor, TIE-2 | 1 | 2021 | 178 | 0.190 |
Why?
|
| Platinum | 1 | 2022 | 233 | 0.190 |
Why?
|
| Protective Agents | 1 | 2021 | 156 | 0.190 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2019 | 86 | 0.170 |
Why?
|
| Metabolomics | 3 | 2021 | 1485 | 0.170 |
Why?
|
| Electric Impedance | 1 | 2023 | 729 | 0.170 |
Why?
|
| Potassium Cyanide | 1 | 2018 | 16 | 0.160 |
Why?
|
| Atrophy | 1 | 2023 | 1584 | 0.160 |
Why?
|
| Anti-Obesity Agents | 1 | 2021 | 217 | 0.160 |
Why?
|
| Animals | 21 | 2023 | 168768 | 0.160 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2018 | 57 | 0.160 |
Why?
|
| Lethal Dose 50 | 1 | 2017 | 77 | 0.150 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 3617 | 0.150 |
Why?
|
| Electron Transport Complex IV | 1 | 2017 | 189 | 0.140 |
Why?
|
| Sulfur | 1 | 2017 | 166 | 0.140 |
Why?
|
| Heart Defects, Congenital | 2 | 2011 | 4583 | 0.140 |
Why?
|
| Proteomics | 1 | 2009 | 3638 | 0.130 |
Why?
|
| Solubility | 1 | 2017 | 1088 | 0.130 |
Why?
|
| Swine | 2 | 2023 | 5918 | 0.130 |
Why?
|
| Signal Transduction | 4 | 2021 | 23404 | 0.120 |
Why?
|
| Gene Deletion | 2 | 2019 | 2751 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 1 | 2004 | 2638 | 0.120 |
Why?
|
| Nitroprusside | 1 | 2013 | 275 | 0.110 |
Why?
|
| Hemodynamics | 1 | 2023 | 4196 | 0.110 |
Why?
|
| Inosine | 1 | 2013 | 133 | 0.100 |
Why?
|
| Endothelium, Vascular | 5 | 2005 | 4459 | 0.100 |
Why?
|
| Zebrafish Proteins | 1 | 2018 | 1005 | 0.100 |
Why?
|
| Metabolome | 1 | 2018 | 895 | 0.100 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 2184 | 0.100 |
Why?
|
| Spectrin | 1 | 2011 | 177 | 0.100 |
Why?
|
| Proteome | 1 | 2021 | 1798 | 0.100 |
Why?
|
| Bile Acids and Salts | 1 | 2013 | 368 | 0.090 |
Why?
|
| Drug Approval | 1 | 2017 | 742 | 0.090 |
Why?
|
| Overweight | 1 | 2021 | 2371 | 0.090 |
Why?
|
| Endothelial Cells | 2 | 2021 | 3486 | 0.090 |
Why?
|
| Neural Tube Defects | 1 | 2011 | 256 | 0.090 |
Why?
|
| Capillaries | 2 | 2002 | 773 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 2023 | 4925 | 0.080 |
Why?
|
| Mice | 13 | 2022 | 81201 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 1375 | 0.070 |
Why?
|
| Amniotic Fluid | 1 | 2009 | 370 | 0.070 |
Why?
|
| Endothelial Growth Factors | 4 | 2002 | 694 | 0.070 |
Why?
|
| STAT2 Transcription Factor | 1 | 2005 | 27 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2011 | 1152 | 0.070 |
Why?
|
| Embryo, Mammalian | 2 | 2011 | 1701 | 0.070 |
Why?
|
| Lymphokines | 4 | 2002 | 949 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 1828 | 0.060 |
Why?
|
| Chromatography, Liquid | 1 | 2009 | 976 | 0.060 |
Why?
|
| Insulin | 1 | 2019 | 6582 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 19905 | 0.060 |
Why?
|
| STAT1 Transcription Factor | 1 | 2005 | 320 | 0.060 |
Why?
|
| Carrier Proteins | 3 | 2011 | 5023 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 18034 | 0.060 |
Why?
|
| Embryonic and Fetal Development | 1 | 2004 | 438 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 13693 | 0.060 |
Why?
|
| Cell Line | 1 | 2017 | 16000 | 0.050 |
Why?
|
| Autocrine Communication | 1 | 2003 | 171 | 0.050 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2002 | 87 | 0.050 |
Why?
|
| Paracrine Communication | 1 | 2003 | 278 | 0.050 |
Why?
|
| Sulfides | 1 | 2022 | 165 | 0.050 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2022 | 249 | 0.050 |
Why?
|
| Sulfonic Acids | 1 | 2021 | 96 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 2204 | 0.050 |
Why?
|
| Interferon-alpha | 1 | 2005 | 895 | 0.050 |
Why?
|
| Pregnancy | 3 | 2009 | 29144 | 0.050 |
Why?
|
| Pyruvic Acid | 1 | 2022 | 200 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 915 | 0.050 |
Why?
|
| Blastocyst | 1 | 2004 | 424 | 0.050 |
Why?
|
| Microcirculation | 1 | 2005 | 1287 | 0.050 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2002 | 282 | 0.050 |
Why?
|
| Angiopoietin-2 | 1 | 2021 | 172 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2002 | 3511 | 0.050 |
Why?
|
| Zinc Fingers | 1 | 2002 | 583 | 0.050 |
Why?
|
| Receptors, Cell Surface | 2 | 2000 | 2865 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2006 | 1115 | 0.040 |
Why?
|
| Obesity | 1 | 2021 | 12746 | 0.040 |
Why?
|
| Protein Engineering | 1 | 2002 | 538 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 4 | 2002 | 772 | 0.040 |
Why?
|
| Vitreous Body | 1 | 2000 | 389 | 0.040 |
Why?
|
| Diet, Reducing | 1 | 2021 | 462 | 0.040 |
Why?
|
| Humans | 14 | 2023 | 744366 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 1678 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2005 | 3207 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 11726 | 0.040 |
Why?
|
| Cysteine | 1 | 2021 | 873 | 0.040 |
Why?
|
| Aniline Compounds | 1 | 2021 | 986 | 0.040 |
Why?
|
| Retinal Detachment | 1 | 2000 | 411 | 0.030 |
Why?
|
| Mammals | 1 | 2022 | 1143 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 1783 | 0.030 |
Why?
|
| Cell Movement | 1 | 2008 | 5218 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2002 | 1504 | 0.030 |
Why?
|
| Ligands | 1 | 2022 | 3282 | 0.030 |
Why?
|
| Gene Expression Regulation | 5 | 2005 | 12073 | 0.030 |
Why?
|
| Skin | 2 | 2005 | 4372 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2000 | 1085 | 0.030 |
Why?
|
| Proteins | 2 | 2000 | 6100 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 2021 | 1161 | 0.030 |
Why?
|
| Female | 8 | 2021 | 380193 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2002 | 12207 | 0.030 |
Why?
|
| Wound Healing | 1 | 2003 | 2785 | 0.030 |
Why?
|
| Neuroepithelial Cells | 1 | 2011 | 22 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2002 | 2038 | 0.030 |
Why?
|
| Ankyrins | 1 | 2011 | 128 | 0.030 |
Why?
|
| Cells, Cultured | 6 | 2005 | 19233 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 7721 | 0.020 |
Why?
|
| Diabetic Retinopathy | 1 | 2000 | 1210 | 0.020 |
Why?
|
| Pseudopodia | 1 | 2011 | 172 | 0.020 |
Why?
|
| Weight Loss | 1 | 2021 | 2625 | 0.020 |
Why?
|
| Protein Stability | 1 | 2011 | 556 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 8642 | 0.020 |
Why?
|
| Craniofacial Abnormalities | 1 | 2011 | 315 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 21833 | 0.020 |
Why?
|
| Heart Failure | 1 | 2013 | 10895 | 0.020 |
Why?
|
| Gene Expression | 1 | 2021 | 7798 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2011 | 645 | 0.020 |
Why?
|
| Apoptosis | 2 | 2005 | 9724 | 0.020 |
Why?
|
| Receptors, Leptin | 2 | 2000 | 361 | 0.020 |
Why?
|
| Myocardium | 1 | 2001 | 4772 | 0.020 |
Why?
|
| Heart | 1 | 2001 | 4464 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2021 | 12025 | 0.020 |
Why?
|
| Body Patterning | 1 | 2011 | 626 | 0.020 |
Why?
|
| Fibroblasts | 2 | 2011 | 4162 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2011 | 711 | 0.020 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2005 | 115 | 0.020 |
Why?
|
| Models, Animal | 2 | 2002 | 2173 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2005 | 351 | 0.020 |
Why?
|
| Middle Aged | 4 | 2021 | 213390 | 0.020 |
Why?
|
| Actins | 1 | 2011 | 2121 | 0.010 |
Why?
|
| Molecular Sequence Data | 3 | 2002 | 18111 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2021 | 12721 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 2005 | 659 | 0.010 |
Why?
|
| Axons | 1 | 2011 | 1685 | 0.010 |
Why?
|
| Cell Division | 2 | 2002 | 4569 | 0.010 |
Why?
|
| Cell Proliferation | 2 | 2011 | 10483 | 0.010 |
Why?
|
| Lung | 1 | 2021 | 9857 | 0.010 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2005 | 894 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2005 | 547 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 2005 | 640 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2011 | 3749 | 0.010 |
Why?
|
| Phenotype | 2 | 2011 | 16367 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2002 | 286 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 1101 | 0.010 |
Why?
|
| Cadherins | 1 | 2005 | 907 | 0.010 |
Why?
|
| Response Elements | 1 | 2002 | 312 | 0.010 |
Why?
|
| Epiretinal Membrane | 1 | 2000 | 68 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2000 | 919 | 0.010 |
Why?
|
| Mitogens | 1 | 2000 | 232 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 57776 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2005 | 3130 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2005 | 13035 | 0.010 |
Why?
|
| Adult | 3 | 2021 | 214052 | 0.010 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2000 | 215 | 0.010 |
Why?
|
| Rats, Zucker | 1 | 1998 | 128 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 2002 | 13814 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2002 | 627 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 40559 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 2700 | 0.010 |
Why?
|
| Male | 4 | 2021 | 350115 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4751 | 0.010 |
Why?
|
| Models, Biological | 2 | 2005 | 9584 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2000 | 599 | 0.010 |
Why?
|
| Gene Expression Profiling | 2 | 2005 | 9445 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2000 | 1799 | 0.010 |
Why?
|
| Drug Design | 1 | 2002 | 1076 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2001 | 1950 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3921 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2000 | 2646 | 0.010 |
Why?
|
| Corneal Neovascularization | 1 | 1998 | 188 | 0.010 |
Why?
|
| Mice, Knockout | 2 | 2002 | 14561 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2000 | 1341 | 0.010 |
Why?
|
| Young Adult | 1 | 2021 | 56429 | 0.010 |
Why?
|
| Antibodies | 1 | 2003 | 2460 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 63107 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2000 | 2716 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2005 | 4026 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2005 | 5974 | 0.010 |
Why?
|
| STAT3 Transcription Factor | 1 | 1998 | 874 | 0.010 |
Why?
|
| Chromatin | 1 | 2005 | 2933 | 0.010 |
Why?
|
| Risk Factors | 1 | 2021 | 72296 | 0.010 |
Why?
|
| Binding Sites | 1 | 2002 | 6111 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 6621 | 0.010 |
Why?
|
| Aged | 2 | 2021 | 163288 | 0.010 |
Why?
|
| Adipocytes | 1 | 1998 | 1185 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 12797 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 5867 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1998 | 1889 | 0.010 |
Why?
|
| Cell Survival | 1 | 2000 | 5882 | 0.010 |
Why?
|
| Trans-Activators | 1 | 1998 | 2926 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 11366 | 0.000 |
Why?
|
| Neoplasm Proteins | 1 | 2000 | 3707 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1998 | 8436 | 0.000 |
Why?
|
| Energy Metabolism | 1 | 1998 | 2897 | 0.000 |
Why?
|
| Rats | 1 | 1998 | 24252 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 1998 | 9647 | 0.000 |
Why?
|
| Child | 1 | 2000 | 77709 | 0.000 |
Why?
|
| Adolescent | 1 | 2000 | 85779 | 0.000 |
Why?
|